Trial Profile
Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary Syndrome
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Drospirenone/ethinylestradiol (Primary) ; Metformin
- Indications Polycystic ovary syndrome
- Focus Pharmacodynamics
- 26 Apr 2012 New trial record